Novast
Nantong
About Novast
Novast is focused on the research, development and manufacture of value-added generic drugs with release control and other dosage types, and sells them into US pharmaceutical market cooperating with US leading channel. Cooperating with US sales channels and original development enterprises, it is the first pharmaceutical enterprise in China selling pharmaceutical products into US local market. Novast Pharmaceutical Company owns cGMP manufacturing facilities covering18, 000 square meters, and its management team has experiences of applying more than 100 generic drug patents in U.S., and many years of working experience in U.S. Novast also independently researches and develops multiple drug-delivery and dosage type technology.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 501 – 1,000
- Estimated revenue: $1K – $10K
- Total funding: $303.5M
- Last round: Series Unknown (Jan 2021)
- Website: novast.cn
- Phone: +86(513)8598 6619
Industries & Categories
Health Care, Manufacturing, Pharmaceutical
Social Profiles
Canonical: https://fsome.com/organization/novast-64243 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.